Decline of circulating CTRP3 levels was linked to insulin resistance in diabetic patients and rise of its levels was noted after treatment with glucagon-like peptide-1 (GLP-1) receptor agonists [20]. This evidence concerns the gene C1QTNF3 and Insulin resistance.